Bactiguard Holding AB
STO:BACTI B
Operating Margin
Bactiguard Holding AB
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| SE |
|
Bactiguard Holding AB
STO:BACTI B
|
810.1m SEK |
-11%
|
|
| CH |
|
Alcon AG
SIX:ALC
|
36.3B CHF |
14%
|
|
| JP |
|
Hoya Corp
TSE:7741
|
5.2T JPY |
28%
|
|
| DK |
|
Coloplast A/S
CSE:COLO B
|
157.3B DKK |
27%
|
|
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
10.9B USD |
17%
|
|
| US |
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
6.5B USD |
29%
|
|
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.8B GBP |
15%
|
|
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
42.5B CNY |
45%
|
|
| US |
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
5.4B USD |
12%
|
|
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
7.3T KRW |
-245%
|
|
| CH |
|
Ypsomed Holding AG
SIX:YPSN
|
4.2B CHF |
14%
|
Bactiguard Holding AB
Glance View
Bactiguard Holding AB is a medical device company, which engages in the development and supply of infection protection solutions. The company is headquartered in Stockholm, Stockholm and currently employs 188 full-time employees. The company went IPO on 2014-06-19. Its technology is based on the Bactiguard Infection Protection (BIP), a thin coating permanently bound to the surface of medical devices. The company consists of the noble metals: gold, palladium and silver, which reduces the adhesion of bacteria to the coated surfaces. Its product portfolio includes: BIP Foley Catherer, made from medical grade latex, and BIP Foley Catheter - Silicone, used for drainage and irrigation of the bladder; BIP Endotracheal Tube, for general anesthesia, intensive care, and emergency medicine for airway management and mechanical ventilation; and BIP Central Venous Catherer, made of polyurethane and used to administer drugs and intravenous solutions, monitor pressure and blood sampling. The firm is also present in Portugal, via a distribution agreement with Socime Medical Ltd, and Zambia.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Bactiguard Holding AB's most recent financial statements, the company has Operating Margin of -11%.
You don't have any saved screeners yet